Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
drugs
2
×
fda
2
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
2
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alder biopharmaceutical
allergan
american academy of neurology
amgen
atogepant
biohaven
biotech
blueprint medicines
bob azelby
botox
brian abrahams
What
drug
2
×
fda
new
2
×
approval
approved
arguments
big
cancer
class
commercialized
companies
competitors
decades
deeper
dna
drugs
fingerprint
genetic
going
make
matter
medicine
meeting
migraine
nd
neuro
oks
oral
potential
second
targets
therapies
time
tissues
tumor's
won
world
year
Language
Current search:
fda
×
drug
×
" seattle blog main "
×
new
×
drugs
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
